Mar 30 2022 By now, many of you have read the CBC news article about a psychedelic-assisted therapeutic session that took place as part of
MAPS Canada is honoured to announce the appointment of Sabrina Ramkellawan and Dr. Rielle Capler to the MAPS Canada Board of Directors. Sabrina Ramkellawan is
September 1st, 2021 MAPS Canada is pleased to announce the appointment of Scott Bernstein as our new Executive Director. A lawyer based in Vancouver, BC,
Neural plasticity has been the subject of much debate, and hype both in the scientific community as well as the general public. At the same
Introduction Over the past several years, MDMA (also known as Ecstasy/Molly) has been making waves in the realms of drug research and therapy, with many
Objective The Center for Psychedelic and Consciousness Research at Johns Hopkins Medical school in Baltimore conducted a randomized, controlled clinical trial to examine if one
Dear MAPS Canada Community, We are very excited to be announcing the release of our brand new MAPS Canada Podcast. This is a project that
April 16, 2021 The MAPS Canada Board of Directors is pleased to announce the appointment of Vivian Smith on April 12, 2021, as the organization’s
Are people of colour included in psychedelic research? In their paper “Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature” Michaels
In Kyle Shannon’s Towards Data Science’s article, “A Guide to Reading Academic Research”, Shannon emphasizes that reading scientific papers is not just for gathering the
Help support equitable access to legal and regulated psychedelic medicine for all Canadians.
Join our mailing list and stay informed of the latest news from MAPS Canada, relevant news about psychedelics from around the world,
and invitations to MAPS Canada virtual events, webinars, in-person events, and more.
